Skip to main content
Porto

Main navigation

  • Home
  • PMMNG Meetings
    • PMMNG Monthly Meetings
    • Steering Committee Meetings
  • Myeloma Events
  • Our Members
  • Miles for Myeloma 5K
  • Diversity & Inclusion
  • Resources
    • Myeloma Education Resources
    • Myeloma and Cancer Foundations
    • Regional Myeloma Support Groups
    • Publications and Newsletters
    • Cancer Support Networks
    • Treatments
    • Financial Assistance
    • Caregivers
  • Clinical Trials

isatuximab

Myeloma Crowd LogoWhat: Webcast
When: Tuesday February 19, 2019
Where: Web

Tags
event
archived
webcast
myeloma crowd
treatment
immunotherapy
monoclonal antibodies
isatuximab
  • Read more about Myeloma Crowd: A New CD38 Monocloncal Antibody Called Isatuximab Gets Closer to the Clinic

Myeloma Crowd logoWhat: Webcast audio (!:09:32)
When: Friday June 5, 2020 7:00 PM ET
Where: Web

Tags
event
events. webcast
archived
myeloma crowd
isatuximab
sarclisa
Dr. Thomas Martin
  • Read more about Myeloma Crowd: Adding Isatuximab (Sarclisa) to the Myeloma Treatment Arsenal

MMRF logoWhat:  Webcast
When: Tuesday, November 17, 2020 100 PM – 2:00 PM ET
Where: Web
View slides

Tags
event
archived
webcast
mmrf
treatment
newly approved drugs
blenrep
belantamab mafodotin
xpovio
selinexor
darzalex faspro
daratumumab and hyaluronidase
sarclisa
isatuximab
Dr. Joshua R. Richter
Dr. Nina Shah
  • Read more about MMRF: Updates on New Drug Approvals and the Expanding Therapeutic Landscape in Multiple Myeloma
Subscribe to isatuximab